番茄社区app

Next step for avutometinib/defactinib combination is going forward with phase III trial

News and commentary from the world of neurology and neuroscience

At 5 years, median PSA was reduced by 90%

Top state had 63 high-performing hospitals, according to annual U.S. News list

Care is evolving to address aspects patients care about, side effects and fatigue

Pharmacists can intervene to educate, assist with cost, two studies suggest

A compliance plan can help optimize clinical decision-making

Greater improvements over apremilast and placebo through 24 weeks

While trial proves "survival can be better than zero," long-term management remains a concern

Other outcomes like blood pressure levels, however, were better than with watchful waiting

Tennessee court rejects former nurse's appeal to overturn nursing board's 2021 decision

Patients with treatment-sensitive disease may benefit most from continued treatment, says expert

Health news and commentary from around the Web gathered by 番茄社区app staff

Intervention persuaded VA physicians to adjust care, helped lower HbA1c